US FDA Authorizes Pfizer’s Covid Booster Shots For Elderly, High-Risk Americans

US Food and Drug Administration (FDA) on Wednesday (local time) authorized booster shots of the Pfizer COVID-19 vaccine for those aged 65 and older and adults at high risk. People over 65 who had received Pfizer-BioNTech’s coronavirus vaccine will get a booster shot at least six months after their second injection, said the US FDA, … Continue reading US FDA Authorizes Pfizer’s Covid Booster Shots For Elderly, High-Risk Americans